— T-Mobile‘s head of home and entertainment, Jeffrey Binder, has left the company. Binder was the CEO of television technology company Layer3 TV, which was acquired by T-Mobile in 2018. Industry publication Light Reading first reported the news.
Launched last month, T-Mobile’s own cord-cutting TV service was built on the Layer3 TV acquisition and led by Binder. The product, called TVision Home, is a set-top box that gets to know users’ viewing habits with personalized DVRs for every member of the household. The service costs $100 per month or $90 for T-Mobile customers.
T-Mobile has said the TV service fits within its 5G network plans, which could one day replace wired broadband from cable companies.
— Maria Hess is the latest partner to join the “startup studio” Madrona Venture Labs, an accelerator from VC firm Madrona Venture Group. Hess was previously vice president of marketing at Likewise, a recommendation platform for everything from books to restaurants that’s backed by Bill Gates.
Prior to Likewise, Hess was chief revenue officer at photo editing and design startup PicMonkey. Hess also held product management roles at Google, Expedia and Amazon.
“I continue to be inspired by the Seattle startup community (last night’s Geekwire Awards highlighted that) and am impressed by the caliber of talent at Madrona Venture Labs. What also stands out is MVL’s pro-diversity hiring culture, something I’m passionate about, given the lack of diversity in our industry. I’m excited to bring my experience in growth marketing to test and elevate best practices for our early-stage companies and founders for a higher probability of success,” Hess said in an email.
Madrona Venture Labs is a 3-month accelerator program that launched last year in a bid to lure talent from tech giants. So far, it has taken in two startups, Invio and Vouched, and plans to launch as many as 12 new companies in the next two years.
— Drug startup Athira Pharma, formerly known as M3 Biotechnology, hired Dr. Hans J. Moebius as chief medical officer. Moebius was most recently vice president of clinical research Europe at FORUM Pharmaceuticals in Switzerland. He has also held senior R&D roles at Ciba-Geigy, Novartis, Merz Pharmaceuticals and TauRx, among others.
“[Moebius] brings decades of experience in neurology research and drug development that will be invaluable to Athira – helping ensure that the science we are advancing is thoughtfully and expertly executed and supporting Athira’s strategy in order to make significant, lasting impacts on human health,” Leen Kawas, CEO of Athira, said in a statement.
“Athira’s pipeline has the potential to truly transform the course of a wider range of devastating diseases,” Moebius said in a statement. “My top priority will be the clinical proof of concept for the lead compound in Alzheimer’s and Parkinson’s Disease, establishing Athira as a leader in a field that has so many patients and their families waiting for progress.”
Athira’s leading drug candidate aims to reduce or reverse the effects of Alzheimer’s and other neurodegenerative diseases. Kawas won Startup CEO of the Year at the 2019 GeekWire Awards.
— Torben S. Nielsen has joined PeaceHealth, an Oregon healthcare system, as senior vice president of business transformation. Nielsen came from Premera Blue Cross, where he was vice president of innovation and strategic investments in Seattle. Nielsen has also worked with health companies Cambia Health Solutions and HealthSparq, as well as XEROX and Lego.
“I spent 12 years primarily on the payer side — it’s time to explore the delivery side!” Nielsen wrote on Twitter.